<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-145887" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>ABO Typing Discrepancies</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fathima</surname>
            <given-names>Saubia</given-names>
          </name>
          <aff>Dubai Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Killeen</surname>
            <given-names>Robert B.</given-names>
          </name>
          <aff>University of Illinois</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Saubia Fathima declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robert Killeen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>12</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-145887.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Modern transfusion medicine prioritizes patient safety and focuses on reducing patient risks with the use of blood products. ABO discrepancies are common obstacles health care professionals encounter in clinical practice. ABO discrepancies describe scenarios that result in unexpected reactions in the ABO forward and reverse typing reactions. This makes the determination of the patient's blood group uncertain and can pose a threat to the patient's safety by transfusion of incompatible blood products. This activity describes the identification, interpretation, evaluation, and management of ABO discrepancies by the interprofessional team when it occurs.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the significance of ABO discrepancies.</p></list-item><list-item><p>Review the interpretation of ABO discrepancies.</p></list-item><list-item><p>Identify the common causes of ABO discrepancies.</p></list-item><list-item><p>Summarize the resolution and management of these discrepancies.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=145887&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=145887">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-145887.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>While transfusion of blood products can be life-saving, it comes with its own risks. With time and experience, many practices have been developed to decrease transfusion-associated complications. Current practices focus on restricting unnecessary blood transfusions. All blood products are extensively tested pretransfusion to ensure safe and compatible transfusions.</p>
        <p>ABO typing of blood products is among the first and basic tests in that process. ABO typing discrepancies pose a significant challenge to safe transfusion practices as they make the determination of the patient's blood group uncertain.<xref ref-type="bibr" rid="article-145887.r1">[1]</xref><xref ref-type="bibr" rid="article-145887.r2">[2]</xref></p>
      </sec>
      <sec id="article-145887.s3" sec-type="Function">
        <title>Function</title>
        <p>The basic principle of ABO typing is that the forward grouping reaction, which detects the antigen present on the surface of the RBCs of the patient, should match the results of the reverse grouping reaction, which detects the antibodies present in the patient&#x02019;s serum. The Anti-A and Anti-B, universally occurring antibodies are expected to be detected in the serum of all persons who lack those antigens on the surface of red blood cells. Both the forward and reverse grouping reactions are expected to be strong (3+ or 4+) reactions.</p>
        <p>If there are any unmatched results between the two grouping reactions, ABO discrepancies arise. It is essential for patient safety that no ABO discrepancies are ignored. All discrepancies should be investigated and explained before determining the patient&#x02019;s blood group and issuing group-compatible blood products.<xref ref-type="bibr" rid="article-145887.r3">[3]</xref><xref ref-type="bibr" rid="article-145887.r1">[1]</xref></p>
        <p>Expected normal ABO typing results&#x000a0;appear in the following table.<xref ref-type="bibr" rid="article-145887.r4">[4]</xref></p>
        <table-wrap id="article-145887.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>Blood Group</p>
</td>
                <td rowspan="1" colspan="1">
<p>Forward reaction&#x000a0; (patient&#x02019;s RBCs with reagent antibodies)</p>
</td>
                <td rowspan="1" colspan="1">
<p>Reserve reaction (Patient&#x02019;s serum with reagent RBCs )</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
</td>
                <td rowspan="1" colspan="1">
<p>Anti A</p>
</td>
                <td rowspan="1" colspan="1">
<p>Anti B</p>
</td>
                <td rowspan="1" colspan="1">
<p>A group RBCs</p>
</td>
                <td rowspan="1" colspan="1">
<p>B group RBC</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>A</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>B</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>O</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>AB</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+ or 4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
                <td rowspan="1" colspan="1">
<p>-</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-145887.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>With the automatization and standardization of testing procedures, the incidence of ABO discrepancies has reduced considerably due to decreased technical errors. However, when these discrepancies occur, they need careful work up for resolution and explanation. When faced with these discrepancies, it is best to rule out technical errors first, which include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Incorrect labeling of samples,</p>
          </list-item>
          <list-item>
            <p>A&#x000a0;wrong technique of the procedure,</p>
          </list-item>
          <list-item>
            <p>Reagent contamination, or expiry.&#x000a0;</p>
          </list-item>
        </list>
        <p>These can be avoided by regular training of lab staff and quality checks of the testing. Any discrepant test result must be repeated with the same or fresh sample if required, and further workup should be done if the discrepancy persists.<xref ref-type="bibr" rid="article-145887.r3">[3]</xref></p>
        <p>For ease of understanding and work up, ABO discrepancies have been divided into four headings; group I, group II, group III, and group IV.<xref ref-type="bibr" rid="article-145887.r5">[5]</xref><xref ref-type="bibr" rid="article-145887.r6">[6]</xref></p>
        <p><bold>Group I:</bold>&#x000a0;Weak or absent reaction in the reverse grouping</p>
        <p>These discrepancies occur when there are decreased antibodies in the patient's serum leading to weak or absent reaction in the reverse grouping.</p>
        <p>The situations which fall in this group include:</p>
        <list list-type="bullet">
          <list-item>
            <p>ABO typing in newborns<xref ref-type="bibr" rid="article-145887.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Occasionally encountered in elderly patients</p>
          </list-item>
          <list-item>
            <p>Patients on immunosuppressant medications which lead to decreased lymphocyte function and antibody production</p>
          </list-item>
          <list-item>
            <p>Congenital immunodeficiency<xref ref-type="bibr" rid="article-145887.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Hypogammaglobulinemia</p>
          </list-item>
          <list-item>
            <p>The absence of anti-B in serum can also be encountered in children in a sterile environment and those on artificial sterile nutrition as they remain unexposed to bacteria.<xref ref-type="bibr" rid="article-145887.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Natural chimerism<xref ref-type="bibr" rid="article-145887.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Chimerism is a rare phenomenon when an individual has two sets of red cells with different blood groups circulating in the body. Both types of red cell antigens are recognized as self-antigens; therefore, no antibodies against them exist in the serum. This gives rise to mixed field reactions in forward grouping reactions and absent reactions in reverse grouping resulting in an ABO discrepancy. This usually occurs in fraternal twins. Most&#x000a0;rarely, chimerism can be found in individuals without fraternal twins due to mosaicism.<xref ref-type="bibr" rid="article-145887.r10">[10]</xref><xref ref-type="bibr" rid="article-145887.r11">[11]</xref></p>
        <p>Workup and resolution: Most causes of these discrepancies will be obvious from the patient's history. To confirm this discrepancy, the missing or weak antibody has to be augmented by incubating the serum with reagent RBCs at room temperature for up to 15&#x000a0;to 30 minutes, after which, in most cases, an acceptable reaction will be recorded. In some cases, if there is no reaction, the sample can be centrifuged to bring the antibodies and cells closer and should be incubated for some time for a reaction.</p>
        <p>If, despite these steps, a reaction is still not obvious, then the mixture of the patient's serum and reagent cells should be incubated at 4&#x000a0;degrees C for up to 30 minutes. Once an expected reaction is recorded, the discrepancy is resolved, and the patient's blood group can be reported with certainty.</p>
        <p><bold>Group II:</bold>&#x000a0;Unexpected reaction in the forward grouping</p>
        <p>These discrepancies occur in patients with weakly reacting antigens (due to low antigen burden on the RBC surface or another antigen similar to AB antigens on the RBC surface reacting with the antibody) or partial deletion of antigens on the surface of cells. These antigens will yield a weaker than expected reaction in the forward typing, which will be unmatched in the reverse typing reaction.</p>
        <p>The situations which can fall into this group include:</p>
        <list list-type="bullet">
          <list-item>
            <p>A or B subgroups (among the most common causes of discrepancies)<xref ref-type="bibr" rid="article-145887.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>B(A) phenotype<xref ref-type="bibr" rid="article-145887.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Acquired B phenomenon</p>
          </list-item>
          <list-item>
            <p>Hematological malignancies can alter the antigens present on the surface of cells (like leukemia and multiple myeloma).<xref ref-type="bibr" rid="article-145887.r13">[13]</xref><xref ref-type="bibr" rid="article-145887.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Pregnancy is also reported to cause weakened ABO expression.</p>
          </list-item>
          <list-item>
            <p>Post-transfusion of a different blood group of red cells&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Post allogenic bone marrow transplant with an ABO incompatible donor</p>
          </list-item>
          <list-item>
            <p>Fetomaternal hemorrhage<xref ref-type="bibr" rid="article-145887.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Tn syndrome<xref ref-type="bibr" rid="article-145887.r16">[16]</xref></p>
          </list-item>
        </list>
        <p>Workup and resolution: the weak reaction in forward typing can be augmented by incubating the mixture for a longer time, up to 30 minutes, at room temperature. If the reaction is not enhanced with longer incubation, then the mixture should be incubated at 4 degrees Celsius for up to 30 minutes. Reviewing a patient's clinical can provide important explanations of the cause of the discrepancy.</p>
        <p>Blood group A subgroups are among the most common causes of ABO discrepancies. Group B subgroups are very rare. In group A, the most common subgroup is A1, followed by A2, which accounts for more than 99% of the A blood group. Other A subgroups like A3 and Ax are very rare. The resolution of discrepancies caused by the A subgroups can be achieved by using Dolichos bilflorus plant seed extract lectin, which agglutinates A1, but not A2, cells. Detection of the presence of A1 antibody in the patient's serum using A1 RBC reagent cells, Detection of secretion A, B, and H substances in patient's saliva, and molecular genotyping studies can also be of value in resolving ABO subgroups.<xref ref-type="bibr" rid="article-145887.r17">[17]</xref><xref ref-type="bibr" rid="article-145887.r18">[18]</xref></p>
        <p>The acquired B antigen is a special situation that occurs when a group A patient during an episode of infection when certain gram-negative bacteria secrete enzymes that can modify the A antigen on the RBC surface, which is N-acetyl-D-galactosamine to D-galactosamine that resembles D-galactose (the B antigen) and will cross-react with anti-B reagents. This phenomenon will resolve once the patient recovers.</p>
        <p>To prove the acquired B phenomenon, the cells should be incubated with the monoclonal anti-B clone, yielding a strong reaction, while the regular B antiserum will yield a weak mix-field reaction only. Also, mixing the patient's sera which contains anti-B antibodies, with the patient's RBCs, with acquired B will not yield any reaction. Acetic anhydride can also be helpful in these cases as it re-acetylates the modified antigen and decreases its reaction to Anti B. The patient's original blood group will be A, and their serum will contain anti-B antibodies. They should receive group A-compatible blood products when needed.<xref ref-type="bibr" rid="article-145887.r19">[19]</xref><xref ref-type="bibr" rid="article-145887.r20">[20]</xref></p>
        <p>Tn syndrome is a rare, acquired, permanent disorder of unknown origin. Anti Tn antibody is a naturally occurring antibody in the serum of most adult humans. In this disorder, the pluripotent stem cells are affected, which causes all cell lineage cells to express Tn-antigen on their surfaces. This leads to mild hemolytic anemia, thrombocytopenia, and leukopenia which usually do not require treatment. This disorder is associated with some blood disorders like leukemia and myelodysplastic disorders, including myeloproliferative neoplasms.<xref ref-type="bibr" rid="article-145887.r16">[16]</xref></p>
        <p>The B(A) phenotype is a rare but autosomal dominant condition in which the patient's red cells predominantly express B antigen, but occasional A antigens are also expressed on the surface. These individuals have anti-A antibodies in the serum. The A antigens on the red cells are very few, so no significant hemolysis occurs, and the affected individuals are asymptomatic. But this leads to ABO discrepancy with an unexpected reaction in forwarding grouping during ABO typing.<xref ref-type="bibr" rid="article-145887.r6">[6]</xref></p>
        <p>The resolution of the rest of the discrepancies will depend on the underlying cause; for example, if the discrepancy is due to a recent blood transfusion, then it is reasonable to repeat the ABO typing at a later date, employ a Kleihauer-Betke (K-B) test when fetomaternal hemorrhage is suspected, etc.</p>
        <p><bold>Group III</bold>: Unmatched reaction between the forward and reverse grouping due to plasma abnormalities</p>
        <p>These discrepancies occur in patients with proteins or plasma abnormalities resulting in rouleaux formation or pseudo agglutination, which will cause false and uninterpretable results.</p>
        <p>Conditions that cause rouleaux formation include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypergammaglobulinemia (as in cases of multiple myeloma)<xref ref-type="bibr" rid="article-145887.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Hyperfibrinogenaemia</p>
          </list-item>
          <list-item>
            <p>Certain plasma expanders like dextran or hydroxyethyl starch<xref ref-type="bibr" rid="article-145887.r21">[21]</xref><xref ref-type="bibr" rid="article-145887.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Contamination with Wharton jelly in cord blood</p>
          </list-item>
        </list>
        <p>
<bold>Work Up and Resolution</bold>
</p>
        <p>The ABO typing detects antigens and antibodies based on agglutination. Rouleaux formation closely resembles the agglutination of red cells and can lead to false positive results. When all reactions result positive in forward and reverse typing, it is important to perform a microscopic examination of the blood sample to document rouleaux. If that is confirmed, washing the sample with normal saline will eliminate other antibodies and other proteins, causing unwanted stacking of red blood cells. It will lead to the resolution of the discrepancy on repeated testing of washed cells.</p>
        <p>In reverse typing discrepancies, it is worthwhile to perform a saline replacement technique, in which, after centrifugation of the patient's blood, the plasma is removed and replaced with saline of equal volume, and the test is performed again. This will remove the excess protein in the patient's serum that is causing rouleaux formation. The test can then be performed without the interference of those proteins and will provide an interpretable result.</p>
        <p><bold>Group IV:</bold>&#x000a0;Unmatched reaction between the forward and reverse grouping due to miscellaneous causes</p>
        <p>Discrepancies due to miscellaneous causes that do not fall into the above groups will fall in group IV. These will be seen in cases when there is an agglutination reaction independent of a specific reagent antibody.&#x000a0;</p>
        <p>Conditions that cause this include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cold reactive autoantibodies</p>
          </list-item>
          <list-item>
            <p>ABO isoagglutinin</p>
          </list-item>
          <list-item>
            <p>Non-ABO alloantibodies</p>
          </list-item>
          <list-item>
            <p>Recent IVIG infusion<xref ref-type="bibr" rid="article-145887.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Reaction to rare antigens or antibodies in the reagent used<xref ref-type="bibr" rid="article-145887.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Workup and Resolution</bold>
</p>
        <p>When unexplained results are encountered in ABO typing that are mainly positive in both forward and reverse grouping reactions, the presence of cold autoantibodies in the patient's serum should be considered. A direct Coomb's test could be positive. In these cases, the patient's RBCs should be incubated at 37&#x000a0;degrees C. In most cases, this will lead to the IgM antibodies becoming inactive. The sample should then be washed three times in saline at 37&#x000a0;degrees C, and the test should then be repeated. This will rid the effect of these antibodies on the test. Rarely, if the previous steps are unsuccessful, then 0.01 M dithiothreitol (DTT) can be added to the patient's RBCs, preventing agglutination due to IgM antibodies.<xref ref-type="bibr" rid="article-145887.r25">[25]</xref></p>
        <p>If the discrepancy is in the reverse grouping test, then the testing should be repeated at 37&#x000a0;degrees C as this will usually stop the interference of the autoantibodies. If an unexpected result is still encountered, a cold autoabsorption test should be performed. The process of autoabsorption involves incubating the patient's RBCs with the patient's serum which will lead to a reaction of autoantibodies with the patient's RBCs and reduce their concentration in the serum. This sample should then be centrifuged to remove the autoantibody-coated RBCs, and the serum can be used for reverse blood grouping.</p>
        <p>A review of the patient's clinical condition and history of medications administered can provide a clue as to the cause of the discrepancy in this group as well. If the reaction is suspected due to the reagent, then testing should be repeated with a different numbered lot of the reagent.</p>
      </sec>
      <sec id="article-145887.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>While some ABO discrepancies can be resolved easily by reviewing the patient's history, others can be quite challenging to resolve. Workup and resolution of a discrepancy are time-consuming. This can be a significant problem in critical and unstable patients when there is an urgent need for blood product transfusion.</p>
        <p>In those situations, patient care must not be compromised, and unmatched universal donor products like O-negative red blood cells are transfused simultaneously with the workup of the discrepancy. The patient's blood group should not be reported until the resolution of the discrepancy is achieved with clear test documentation.<xref ref-type="bibr" rid="article-145887.r1">[1]</xref></p>
      </sec>
      <sec id="article-145887.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A basic understanding of ABO blood grouping and ABO discrepancies of all healthcare providers who deal with the preparation and administration of blood products is essential for patient safety. Understanding clinical implications, the importance of the ABO discrepancies, and the time-consuming nature of their resolution will lead to better cooperation amongst health care professionals and improve patient outcomes.</p>
        <p>All interprofessional healthcare team members need to be familiar with ABO typing discrepancies and communicate to other team members for intervention when they observe any issues; this will enhance patient care. [Level5]</p>
      </sec>
      <sec id="article-145887.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=145887&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=145887">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/145887/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=145887">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-145887.s8">
        <title>References</title>
        <ref id="article-145887.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sha</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Influence Factor Analysis of ABO Typing Discrepancy Among Patients in a Tertiary Hospital.</article-title>
            <source>Clin Lab</source>
            <year>2021</year>
            <month>Nov</month>
            <day>01</day>
            <volume>67</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">34758226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>The Lancet Haematology</surname>
              </name>
            </person-group>
            <article-title>Updates on blood transfusion guidelines.</article-title>
            <source>Lancet Haematol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>12</issue>
            <fpage>e547</fpage>
            <pub-id pub-id-type="pmid">27890071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Javadzadeh Shahshahani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hayati</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Blood Group Discrepancies at a Regional Blood Center.</article-title>
            <source>Int J Hematol Oncol Stem Cell Res</source>
            <year>2020</year>
            <month>Jan</month>
            <day>01</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-44</page-range>
            <pub-id pub-id-type="pmid">32337013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meny</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Recognizing and resolving ABO discrepancies.</article-title>
            <source>Immunohematology</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>76</fpage>
            <page-range>76-81</page-range>
            <pub-id pub-id-type="pmid">28657767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jekarl</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Combined Group I and III ABO Discrepancies in Multiple Myeloma with IgG-Lambda Type: A Case Report.</article-title>
            <source>Med Princ Pract</source>
            <year>2017</year>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>90</fpage>
            <page-range>90-92</page-range>
            <pub-id pub-id-type="pmid">27595536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marwaha</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>An ABO blood grouping discrepancy: Probable B(A) phenotype.</article-title>
            <source>Transfus Apher Sci</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>56</volume>
            <issue>3</issue>
            <fpage>459</fpage>
            <page-range>459-460</page-range>
            <pub-id pub-id-type="pmid">28571931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>YZ</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>[ABO blood group typing for infants and its application for clinical transfusion].</article-title>
            <source>Zhongguo Shi Yan Xue Ye Xue Za Zhi</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>301</fpage>
            <page-range>301-4</page-range>
            <pub-id pub-id-type="pmid">12844418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A novel Bruton tyrosine kinase gene variation was found in an adult with X-linked agammaglobulinemia during blood cross-matching prior to surgical operation.</article-title>
            <source>Transfus Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>364</fpage>
            <page-range>364-368</page-range>
            <pub-id pub-id-type="pmid">31115091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gabert</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Yazer</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Unexpectedly Weak Anti-B in 2 Group O Pediatric Patients on Parenteral Nutrition and Disease Specific Supplemental Enteral Feeds.</article-title>
            <source>Lab Med</source>
            <year>2020</year>
            <month>May</month>
            <day>06</day>
            <volume>51</volume>
            <issue>3</issue>
            <fpage>296</fpage>
            <page-range>296-300</page-range>
            <pub-id pub-id-type="pmid">31583399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharpe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cote</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hosseini-Maaf</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olsson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Hult</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Mixed field reactions in ABO and Rh typing chimerism likely resulting from twin haematopoiesis.</article-title>
            <source>Blood Transfus</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>608</fpage>
            <page-range>608-10</page-range>
            <pub-id pub-id-type="pmid">24887220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Yazer</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Ryang</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>A dispermic chimera with mixed field blood group B and mosaic 46,XY/47,XYY karyotype.</article-title>
            <source>J Korean Med Sci</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>553</fpage>
            <page-range>553-6</page-range>
            <pub-id pub-id-type="pmid">17596670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaur</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Blood group discrepancies at a tertiary care centre - analysis and resolution.</article-title>
            <source>Int J Lab Hematol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>481</fpage>
            <page-range>481-7</page-range>
            <pub-id pub-id-type="pmid">24325154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waleed</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sadiq</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Multiple Myeloma and Change of ABO Blood Group Type: A Case Report.</article-title>
            <source>Cureus</source>
            <year>2020</year>
            <month>Sep</month>
            <day>25</day>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>e10654</fpage>
            <pub-id pub-id-type="pmid">33133824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nambiar</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Narayanan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Vijayalakshmi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Blood group change in acute myeloid leukemia.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-75</page-range>
            <pub-id pub-id-type="pmid">28127141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Maternal ABO Discrepancy Caused by Massive Fetomaternal Hemorrhage: a Case Report.</article-title>
            <source>Clin Lab</source>
            <year>2021</year>
            <month>Jun</month>
            <day>01</day>
            <volume>67</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">34107644</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achram</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Denomme</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Stef</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>TTA</given-names>
              </name>
              <name>
                <surname>Delvadia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Josephson</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Roback</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>A case of Tn polyagglutination discovered by an ABO blood group discrepancy.</article-title>
            <source>Transfusion</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>62</volume>
            <issue>7</issue>
            <fpage>1452</fpage>
            <page-range>1452-1456</page-range>
            <pub-id pub-id-type="pmid">35748659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Molecular basis of weak A subgroups in the Korean population: Identification of three novel subgroup-causing variants in the ABO regulatory regions.</article-title>
            <source>Transfusion</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>286</fpage>
            <page-range>286-291</page-range>
            <pub-id pub-id-type="pmid">34786713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Molecular analysis of 23 cases of B subgroup].</article-title>
            <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>
            <year>2022</year>
            <month>May</month>
            <day>10</day>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>546</fpage>
            <page-range>546-547</page-range>
            <pub-id pub-id-type="pmid">35598276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerbal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ropars</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[Acquired B antigen].</article-title>
            <source>Rev Fr Transfus Immunohematol</source>
            <year>1976</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <page-range>127-44</page-range>
            <pub-id pub-id-type="pmid">61608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Acquired B antigen: an ABO typing discrepancy successfully reversed by transfusion with type A red blood cells.</article-title>
            <source>Transfusion</source>
            <year>1980</year>
            <season>Jul-Aug</season>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>467</fpage>
            <page-range>467-70</page-range>
            <pub-id pub-id-type="pmid">6996232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goto</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Difficulty in blood typing after infusion of plasma substitutes. Relationship to erythrocyte sedimentation rate and rouleaux-formation.</article-title>
            <source>Jpn J Surg</source>
            <year>1974</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>216</fpage>
            <page-range>216-21</page-range>
            <pub-id pub-id-type="pmid">4465473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daniels</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Smith-Floss</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Effects of hydroxyethyl starch on erythrocyte typing and blood crossmatching.</article-title>
            <source>Transfusion</source>
            <year>1982</year>
            <season>May-Jun</season>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>226</fpage>
            <page-range>226-8</page-range>
            <pub-id pub-id-type="pmid">6178192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Branch</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Serologic problems associated with administration of intravenous immune globulin (IVIg).</article-title>
            <source>Immunohematology</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-15</page-range>
            <pub-id pub-id-type="pmid">30908073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strobel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>False-positive reactions of some monoclonal anti-c reagents.</article-title>
            <source>Transfus Med</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>141</fpage>
            <page-range>141-5</page-range>
            <pub-id pub-id-type="pmid">19566672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-145887.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wasnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lahare</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jagzape</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chandrakar</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient.</article-title>
            <source>Asian J Transfus Sci</source>
            <year>2021</year>
            <season>Jul-Dec</season>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-249</page-range>
            <pub-id pub-id-type="pmid">34908764</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
